Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407809 · ClinicalTrials.gov registry record · Phase 1
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy
A Phase 1 study of Idiopathic Intracranial Hypertension (IIH), sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01407809 is a Phase 1 study of Idiopathic Intracranial Hypertension (IIH) that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01407809, a Phase 1 study of Idiopathic Intracranial Hypertension (IIH), has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Idiopathic Intracranial Hypertension (IIH) is a disease that affects mainly young people, and is associated with headache and loss of vision. The medical and surgical management of IIH is problematic and many patients are not treated effectively. Some cases of IIH are associated with severe stenosis of the large veins of the brain and various researchers have recently reported significant improvement in patients with IIH after the narrow veins of the brain were treated with a stent. Our project aims to evaluate the safety and long-term efficacy of venous sinus stenting in patients with severe IIH refractory to medical management.
Conditions Studied
Interventions
- DEVICE Venous Sinus Stenting
Study Locations (1)
New York
- New York Presbyterian/ Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2020-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01407809
The ClinicalTrials.gov registry entry for NCT01407809 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Idiopathic Intracranial Hypertension (IIH) appearing as the primary indexed condition, and to 1 intervention - of which Venous Sinus Stenting is the first listed.
NCT01407809 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01407809 about?
NCT01407809 is a clinical study titled "Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy". Idiopathic Intracranial Hypertension (IIH) is a disease that affects mainly young people, and is associated with headache and loss of vision. The medical and surgical management of IIH is problematic and many patients are not treated effectively. Some cases of IIH are associated with severe stenosis...
What is the current status of trial NCT01407809?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2020-06-01.
What conditions does trial NCT01407809 study?
This clinical trial studies the following conditions: Idiopathic Intracranial Hypertension (IIH).
What interventions are being tested in trial NCT01407809?
The interventions under investigation include: Venous Sinus Stenting (DEVICE).
Who is sponsoring clinical trial NCT01407809?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01407809 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Idiopathic Intracranial Hypertension (IIH)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.